Company Filing History:
Years Active: 2013
Title: Anabel Álvarez Acosta: Innovator in Biomedicine
Introduction
Anabel Álvarez Acosta is a prominent inventor based in Ciudad de la Habana, Cuba. She has made significant contributions to the field of biomedicine, particularly in the development of vaccines. Her innovative work focuses on engineering pertactin variants for vaccine use, showcasing her dedication to advancing medical science.
Latest Patents
Anabel holds 1 patent for her invention titled "Engineered pertactin variants for vaccine use." This invention is related to the engineering of the Pertactin protein (Prn) and its application in bacterial vaccines, specifically as part of acellular vaccines. The engineered Prn molecules incorporate polymorphisms from different strains, inducing immune responses with protective capacity and opsonophagocytic activity that surpass those generated by existing vaccines. These engineered Prn variants have potential applications in both human and veterinary medicine.
Career Highlights
Anabel is affiliated with the Centro de Ingeniería Genética y Biotecnología, where she continues to push the boundaries of vaccine development. Her work is characterized by a commitment to improving public health through innovative biotechnological solutions.
Collaborations
Anabel collaborates with esteemed colleagues such as Diógenes Quintana Vázquez and Tamara Menendez Medina, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Anabel Álvarez Acosta exemplifies the spirit of innovation in biomedicine through her groundbreaking work on engineered pertactin variants. Her contributions are vital for the advancement of effective vaccines, highlighting her role as a key figure in the field.